A NON-BINDING Letter of Intent has been received by MedAdvisor Solutions pitching an acquisition of its Australia and New Zealand division.
According to an ASX update, the company said the proposal is currently "commercial in confidence" but that directors will carry out due diligence.
MedAdvisor said the latest offer is for a "materially higher value" than what the current share price may imply.
The company said its ANZ division continues to perform strongly, with the latest results issued last month detailing record revenue of $2.9 million.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 May 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 25
